Showing results (211-220 of 357) with videos related to

Sort By:
Pageof 36
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
Frontiers in Immunology|September 6, 2021
Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® MoleculesMarina Tuyishime, Amir Dashti, Katelyn Faircloth, et al.
AIDS (London, England)|October 6, 2011
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)Robert J McLinden, Robert M Paris, Victoria R Polonis, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Augmenting the Activity of Macrolide Adjuvants against Acinetobacter baumanniiVeronica B Hubble, Kyle R Bartholomew, Alexander W Weig, et al.
Chemistry & Biology|October 3, 2003
Accessibility of nuclear chromatin by DNA binding polyamidesBrigitte Dudouet, Ryan Burnett, Liliane A Dickinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2018
HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope BreadthsShabnum Patel, Elizabeth Chorvinsky, Shuroug Albihani, et al.
The Journal of Clinical Investigation|June 26, 2020
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodiesMarina Tuyishime, Carolina Garrido, Shalini Jha, et al.
Frontiers in Cellular and Infection Microbiology|October 3, 2025
Mechanisms of antibiofilm compounds JG-1 and M4 across multiple species: alterations of protein interactions essential to biofilm formationAliyah N Bennett, Jacob F Maziarz, Baileigh Laipply, et al.
Bioorganic & Medicinal Chemistry|September 30, 2017
Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteriaWilliam T Barker, Sara E Martin, Courtney E Chandler, et al.
European Journal of Medicinal Chemistry|June 5, 2026
IMD-0354 optimization generates potent colistin adjuvants with in vivo activity and reduced eukaryotic toxicityLuke J Cowart, Ansley M Nemeth, Leigh A Jania, et al.
Pageof 36